What is Cardinal Health's stock symbol?
Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?
Cardinal Health announced a quarterly dividend on Thursday, February 2nd. Shareholders of record on Monday, April 3rd will be paid a dividend of $0.4489 per share on Saturday, April 15th. This represents a $1.80 annualized dividend and a yield of 2.20%. The ex-dividend date is Thursday, March 30th.
Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?
16 analysts have issued 12-month target prices for Cardinal Health's shares. Their forecasts range from $79.00 to $111.00. On average, they anticipate Cardinal Health's share price to reach $89.50 in the next twelve months.
When will Cardinal Health announce their earnings?
Cardinal Health is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.
What are analysts saying about Cardinal Health stock?
Here are some recent quotes from research analysts about Cardinal Health stock:
According to Zacks Investment Research, "Cardinal Health ended second-quarter fiscal 2017 on a stable note boosted by strong numbers from both the Pharmaceutical and Medical segments. However over the past one year, Cardinal Health underperformed the broader industry with respect to price performance. The company is banking on strategic buyouts (Lymphoseek), joint ventures and supply agreements to drive growth. Cardinal Health also announced that it will bring its powder-free gloves product line to Hong Kong, thus fortifying its footprint in Asia. The company continues to believe that China presents significant growth opportunities. On the flip side, increasing generic pricing pressure remains a major concern for the coming quarters. Moreover, intensifying competition, customer concentration and higher leverage are the primary headwinds. Sluggish macroeconomic situations, competitive markets & a tough product pricing environment are also likely to dent growth." (2/10/2017)
Leerink Swann analysts commented, "We were disappointed by the pharmaceutical operating margin of 1.92% (-24 bps y/y) which was below our 2.02%E, though operating income itself was ahead of our estimate. The Medical division revenue was slightly ahead of our model, and operating income of $122M (margin of 3.80% vs. 4.49%E) was roughly in-line. Cordis is seasonal in nature and as a result earnings were good in Medical last quarter. F2017 Outlook Tough but Long-term +10-15% EPS Growth Guidance Good. Management provided F2017 guidance of $5.48-$5.73. The midpoint of guidance of $5.61 is below consensus of $5.69 and CAH indicated that F1Q:17 pharma operating income would decline in the ‘high teens to low twenty percent range,’ though be flat for F2017 relative to F2016. While this would normally be highly worrisome, management did a good job explaining that F1Q:16 EPS grew +38% y/y and the comp. is difficult due largely to generic pricing trends. In CAH’s prepared presentation, and on the call, management highlighted that they ‘aspire’ to grow adjusted EPS by +10-15% y/y over the longer term. Net customer activity and pricing is expected to have a ($0.55) headwind on F2017 results, tied mainly to Safeway, generic deflation, and less incremental earnings from new generic launches and Red Oak." (8/3/2016)
Who owns Cardinal Health stock?
Cardinal Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock, Inc (7.50%), Barrow Hanley Mewhinney & Strauss LLC (6.68%), State Street Corp (5.19%), Vulcan Value Partners LLC (1.37%), FMR LLC (1.26%) and Franklin Resources Inc. (0.67%). Company insiders that own Cardinal Health stock include Carole S Watkins, Colleen F Arnold, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison, Richard C Notebaert and Stuart G Laws.
Who sold Cardinal Health stock? Who is selling Cardinal Health stock?
Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, Janus Capital Management LLC, AQR Capital Management LLC, Putnam Investments LLC, I.G. Investment Management LTD., FMR LLC, Raymond James Financial Services Advisors Inc. and Artemis Investment Management LLP. Company insiders that have sold Cardinal Health stock in the last year include Carole S Watkins, Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws.
Who bought Cardinal Health stock? Who is buying Cardinal Health stock?
Cardinal Health's stock was bought by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Vulcan Value Partners LLC, Franklin Resources Inc., DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Russell Investments Group Ltd., Baupost Group LLC MA, Credit Agricole S A and State Street Corp.
How do I buy Cardinal Health stock?
Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Cardinal Health stock cost?
One share of Cardinal Health stock can currently be purchased for approximately $81.73.